PMID- 21785041 OWN - NLM STAT- MEDLINE DCOM- 20120914 LR - 20120301 IS - 1460-2385 (Electronic) IS - 0931-0509 (Linking) VI - 27 IP - 3 DP - 2012 Mar TI - Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients. PG - 1070-5 LID - 10.1093/ndt/gfr417 [doi] AB - BACKGROUND: The impact of serum lipid abnormalities on the progression of diabetic kidney disease (DKD) remains conflicting. Furthermore, gender differences in the association between dyslipidaemia and outcome of DKD are largely unknown. We therefore conducted this single-centre observational cohort study to clarify gender differences in the association between serum lipid profiles and the progression of DKD. METHODS: Seven hundred and twenty-three Japanese type 2 diabetes mellitus (T2DM) patients with normoalbuminuria or microalbuminuria, 280 women and 443 men, with a mean (+/- SD) age of 63 +/- 11 years were studied. The endpoint was the progression to a more advanced stage of albuminuria. For statistical analyses, Cox proportional hazard model analyses were conducted. RESULTS: During the mean follow-up period of 4.3 years, 62 of 477 patients with normoalbuminuria and 69 of 246 patients with microalbuminuria reached the endpoint. A significant interaction between high-density lipoprotein (HDL) cholesterol and gender was detected (P(interaction) = 0.04); therefore, separate analyses were conducted for men and women. Overall, in men, the univariate Cox proportional hazard model revealed that higher triglycerides and lower HDL cholesterol levels were significantly associated with higher risk of reaching the endpoint. In the multivariate Cox proportional hazard model, only HDL cholesterol levels remained as an independent predictor of the endpoint (hazard ratio 0.391, P = 0.01). In women, no serum lipid parameters were associated with the endpoint. CONCLUSIONS: Lower HDL cholesterol levels seem to be associated with the progression of DKD in men but not in women. FAU - Hanai, Ko AU - Hanai K AD - Division of Nephrology and Hypertension, Diabetes Centre, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. FAU - Babazono, Tetsuya AU - Babazono T FAU - Yoshida, Naoshi AU - Yoshida N FAU - Nyumura, Izumi AU - Nyumura I FAU - Toya, Kiwako AU - Toya K FAU - Hayashi, Toshihide AU - Hayashi T FAU - Bouchi, Ryotaro AU - Bouchi R FAU - Tanaka, Nobue AU - Tanaka N FAU - Ishii, Akiko AU - Ishii A FAU - Iwamoto, Yasuhiko AU - Iwamoto Y LA - eng PT - Clinical Trial PT - Journal Article DEP - 20110722 PL - England TA - Nephrol Dial Transplant JT - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association JID - 8706402 RN - 0 (Cholesterol, HDL) RN - 0 (Triglycerides) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Albuminuria/etiology/metabolism/pathology MH - Cholesterol, HDL/*metabolism MH - Cohort Studies MH - Diabetes Complications/*etiology/metabolism/pathology MH - Diabetes Mellitus, Type 2/*physiopathology MH - Diabetic Nephropathies/*etiology/metabolism/*pathology MH - Female MH - Follow-Up Studies MH - Glomerular Filtration Rate MH - Humans MH - Incidence MH - Japan/epidemiology MH - Male MH - Middle Aged MH - Prognosis MH - Risk Factors MH - Sex Factors MH - Triglycerides/metabolism MH - Young Adult EDAT- 2011/07/26 06:00 MHDA- 2012/09/15 06:00 CRDT- 2011/07/26 06:00 PHST- 2011/07/26 06:00 [entrez] PHST- 2011/07/26 06:00 [pubmed] PHST- 2012/09/15 06:00 [medline] AID - gfr417 [pii] AID - 10.1093/ndt/gfr417 [doi] PST - ppublish SO - Nephrol Dial Transplant. 2012 Mar;27(3):1070-5. doi: 10.1093/ndt/gfr417. Epub 2011 Jul 22.